HCA Holdings Inc Stock News

HCA Healthcare's (HCA) third-quarter results are likely to reflect an increased occupancy rate and a lower average length of stay.

HCA Healthcare (HCA) closed the most recent trading day at $237.42, moving +1.04% from the previous trading session.

HCA Healthcare's consistent growth trajectory, ample liquidity, superior profitability, and attractive valuation make it a favorable investment. The company's fundamentals have shown consistent growth

Today, the company's earnings continue to beat expectations and management is revising revenue and earnings upwards for 2023.

The U.S. economy added 336,000 jobs in September 2023, well above an upwardly revised 227,000 in August, and beating market forecasts of 170,000.

HCA Healthcare (HCA) closed at $243.36 in the latest trading session, marking a -0.25% move from the prior day.

The healthcare sector is experiencing a post-pandemic recovery, driven by increased costs, nursing shortages, and a growing aging population. The aging population in the US is expected to double withi

As of September 19, S&P 500 healthcare stocks were down 3.2% for the year. Of the 11 sectors, its year to date (YTD) performance is the second worst only behind utilities.

We have narrowed our search to five stocks from defensive sectors. These are: PEP, PG, AWK, VST, HCA.

Cost optimization efforts and rising patient volumes for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving occupancy rates.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

With seniors resuming delayed elective procedures, demand for services provided by HCA Healthcare (HCA) is likely to rise.

Zacks.com users have recently been watching HCA (HCA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

We have narrowed our search to five U.S. corporate behemoth with strong potential for the rest of 2023. These stocks are: JPM, MCD, PEP, ADP, HCA.

HCA (HCA) possesses solid growth attributes, which could help it handily outperform the market.